today, FDA is releasing three new important policy documents related to compounding:
- Revised Draft Guidance: Insanitary Conditions at Compounding Facilities
- Final Guidance: Compounding and Repackaging of Radiopharmaceuticals by State-Licensed Nuclear Pharmacies, Federal Facilities, and Certain Other Entities
- Final Guidance: Compounding and Repackaging of Radiopharmaceuticals by Outsourcing Facilities
No comments:
Post a Comment